Across TCGA pan-cancer cohorts, KCNMB1 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of KCNMB1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where KCNMB1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types KCNMB1 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.
COAD and LSCC are the cancer types where KCNMB1 tumor–normal differential expression is most reproducible.